Cadherins are integral membrane glycoproteins that mediate calcium-dependent, homophilic cell-cell adhesion and are implicated in controlling tissue morphogenesis. T-cadherin is anchored to the membrane through a glycosyl phosphatidylinositol (Ranscht B, Dours-Zimmermann MT: Neuron 7:391-402, 1991) and expressed in a restricted pattern in developing embryos (Ranscht B, Bronner-Fraser M: Development 111:15-22, 1991). We report here the molecular and functional characterization of the T-cadherin isoform, T-cadherin 2 (Tcad-2) and the expression of the corresponding mRNA. Tcad-2 cDNA differs in its 3' nucleotide sequence from T-cadherin cDNA and encodes a protein in which the carboxy terminal Leu of T-cadherin is substituted by Lys and extended by the amino acids SerPheProTyrVal. By RNase protection, mRNAs encoding the T-cadherin isoforms are coexpressed in heart, muscle, liver, skin, somites, and in neural tissue. Many tissues contain both T-cadherin and Tcad-2 mRNAs in conjunction with N-cadherin transcripts, and T-cadherins and N-cadherin proteins are coexpressed on the surface of individual neurons in vitro. Expression in Chinese hamster ovary cells (CHO) revealed that Tcad-2 is a glycosyl phosphatidylinositol-anchored membrane protein that functions in calcium-dependent, homophilic cell adhesion. The identification of a functional T-cadherin isoform and the coexpression of T-cadherins and N-cadherin by individual cells suggest that specific adhesive interactions of embryonic cells may involve a complex interplay between multiple cadherins.

Download full-text PDF

Source
http://dx.doi.org/10.1002/jnr.490340610DOI Listing

Publication Analysis

Top Keywords

t-cadherin
10
cell adhesion
8
calcium-dependent homophilic
8
t-cadherin isoform
8
t-cadherin tcad-2
8
t-cadherins n-cadherin
8
t-cadherin molecular
4
molecular characterization
4
characterization function
4
function cell
4

Similar Publications

Background And Aims: Cadherins are adhesion proteins, and their dysregulation may result in the development of atherosclerosis, plaque rupture, or lesions of the vascular wall. The aim of the present study was to detect the associations of cadherins-P, -E, and -H, with atherosclerosis and pathological cardiovascular conditions.

Methods And Results: The present study with 3-year follow up evaluated atherosclerosis and fasting levels of P-, E-, and H-cadherins in the serum samples of 214 patients in a hospital setting.

View Article and Find Full Text PDF

Introduction: T-cadherin, a non-canonical member of the cadherin superfamily, was initially identified for its involvement in homophilic recognition within the nervous and vascular systems. Apart from its adhesive function, T-cadherin acts as a receptor for two ligands: LDL, contributing to atherogenic processes, and HMW adiponectin, a hormone with well-known cardiovascular protective properties. However, the precise role of T-cadherin in adipose tissue remains elusive.

View Article and Find Full Text PDF
Article Synopsis
  • Cadherin 2 (CDH2) and Cadherin 13 (CDH13) significantly influence the progression and prognosis of various cancers, but their specific roles in adrenocortical carcinoma (ACC) are not well understood.
  • In a study of 75 ACC patients, CDH2 was found to be downregulated and CDH13 upregulated, affecting patient prognosis and showing a complex network of interactions with neighboring genes related to tumor development and metabolism.
  • Moreover, CDH13 expression correlated positively with immune cell infiltration in ACC, and treatments like anti-PD1 immunotherapy were shown to alter its expression; thus, CDH2 and CDH13 may be viable targets for
View Article and Find Full Text PDF

BCR-ABL1-independent resistance to imatinib has no effective treatment due to its complexity and diversity. We previously reported that the CDH13 oncogene was expressed at low levels in BCR-ABL1-independent resistant CML cell lines. However, its effects on CML resistant cells and mechanisms remain unknown.

View Article and Find Full Text PDF

Idiopathic pulmonary fibrosis (IPF) is a progressive, irreversible respiratory disease with limited therapeutic options. A hallmark of IPF is excessive fibroblast activation and extracellular matrix (ECM) deposition. The resulting increase in tissue stiffness amplifies fibroblast activation and drives disease progression.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!